KLDO - Kaleido Biosciences - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-16.78M

Cash

38.47M

Avg Qtr Burn

-19.27M

Short % of Float

5.51%

Insider Ownership

0.73%

Institutional Own.

0.00%

Qtr Updated

12/31/21

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
KB195 Details UCD (Urea Cycle Disorders)	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KB295 Details Inflammatory bowel disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KB109 Details Chronic obstructive pulmonary disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.